Cargando…
Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies
Dysproteinemias progress through a series of clonal evolution events in the tumor cell along with the development of a progressively more “permissive” immune tumor microenvironment (iTME). Novel multiparametric cytometry approaches, such as cytometry by time-of-flight (CyTOF) combined with novel gat...
Autores principales: | Kourelis, Taxiarchis V., Villasboas, Jose C., Jessen, Erik, Dasari, Surendra, Dispenzieri, Angela, Jevremovic, Dragan, Kumar, Shaji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713712/ https://www.ncbi.nlm.nih.gov/pubmed/31462637 http://dx.doi.org/10.1038/s41408-019-0234-4 |
Ejemplares similares
-
An atlas of the bone marrow bone proteome in patients with dysproteinemias
por: Ho, Matthew, et al.
Publicado: (2023) -
An atlas of the bone marrow bone proteome in patients with dysproteinemias
por: Ho, Matthew, et al.
Publicado: (2023) -
Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression
por: Visram, Alissa, et al.
Publicado: (2021) -
Prognostic Significance of Circulating Plasma Cells by Multi-Parametric Flow Cytometry in Light Chain Amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2018) -
N-Glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression
por: Dispenzieri, Angela, et al.
Publicado: (2020)